Global Product Manager
- Marketing
- Denmark - Søborg
Novo Nordisk is preparing to enter a new exciting therapeutic area with liraglutide 3 mg, which is an investigational treatment in phase III development for people with obesity. We are looking for a Global Product Manager to join the Global Marketing team.
The department
You get the opportunity to join an expanding and high performing team of marketing colleagues in Søborg, Denmark. You will report to the Director of Obesity Marketing, and work closely with the Project Lead for Strategic Communications. You will have cross functional interactions with multiple stakeholders in HQ and affiliates, including Global Marketing and Medical Affairs, Medical and Science, Regulatory, Legal, Corporate Communications, and Public Affairs. You can expect 40-60 travel days per year.
The job
You will be responsible for projects to verify and communicate the medical unmet needs for treatment of people with obesity. Your primary task will be to discover and understand the needs for new treatment options in obesity as well as develop plans and tactics to improve medical care for people with obesity. This includes project management working closely with internal and external stakeholders to ensure timely execution at high quality. You will also drive development and execution of communication and publication plans relating to the projects.
Qualifications
To successfully master the job you have international experience from the pharmaceutical industry along with experience in planning and execution of major projects. You have a business or scientific degree, and minimum 5 years’ experience from a pharmaceutical marketing function at global or national level is required. On the personal side, strong communication skills and analytical skills are needed, as well as a proven ability to work independently and efficiently with various external and internal stakeholders.
At Novo Nordisk, we strive for excellence. As a world leader in diabetes care and a major player in haemostasis management, growth hormone therapy and hormone replacement therapy, we offer our employees opportunities for continuous growth.
Contact
For further information please contact Charlotte Østerlund at +45 3079 8634.
Deadline
9 June 2013
- Marketing
- Denmark - Søborg
Novo Nordisk is preparing to enter a new exciting therapeutic area with liraglutide 3 mg, which is an investigational treatment in phase III development for people with obesity. We are looking for a Global Product Manager to join the Global Marketing team.
The department
You get the opportunity to join an expanding and high performing team of marketing colleagues in Søborg, Denmark. You will report to the Director of Obesity Marketing, and work closely with the Project Lead for Strategic Communications. You will have cross functional interactions with multiple stakeholders in HQ and affiliates, including Global Marketing and Medical Affairs, Medical and Science, Regulatory, Legal, Corporate Communications, and Public Affairs. You can expect 40-60 travel days per year.
The job
You will be responsible for projects to verify and communicate the medical unmet needs for treatment of people with obesity. Your primary task will be to discover and understand the needs for new treatment options in obesity as well as develop plans and tactics to improve medical care for people with obesity. This includes project management working closely with internal and external stakeholders to ensure timely execution at high quality. You will also drive development and execution of communication and publication plans relating to the projects.
Qualifications
To successfully master the job you have international experience from the pharmaceutical industry along with experience in planning and execution of major projects. You have a business or scientific degree, and minimum 5 years’ experience from a pharmaceutical marketing function at global or national level is required. On the personal side, strong communication skills and analytical skills are needed, as well as a proven ability to work independently and efficiently with various external and internal stakeholders.
At Novo Nordisk, we strive for excellence. As a world leader in diabetes care and a major player in haemostasis management, growth hormone therapy and hormone replacement therapy, we offer our employees opportunities for continuous growth.
Contact
For further information please contact Charlotte Østerlund at +45 3079 8634.
Deadline
9 June 2013